Glaucoma 2.0: Neuroprotection, neuroregeneration, neuroenhancement

Ophthalmology

Volumn 119, Issue 5, 2012, Pages 979-986

  Chang, Elma E ^a   Goldberg, Jeffrey L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; BRAIN DERIVED NEUROTROPHIC FACTOR; BRIMONIDINE; CALCIUM CHANNEL BLOCKING AGENT; MEMANTINE; NERVE GROWTH FACTOR;

ARGON LASER; BRAIN ELECTROPHYSIOLOGY; CELL FUNCTION; CELL JUNCTION; CELL SURVIVAL; DRUG FORMULATION; ELECTROSTIMULATION THERAPY; EXCITOTOXICITY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NERVE FIBER REGENERATION; NEUROENHANCEMENT; NEUROLOGICAL AND SENSORIAL PROCEDURES; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; STEM CELL TRANSPLANTATION; TRABECULECTOMY; TRABECULOPLASTY; VISUAL FIELD;

ANTIHYPERTENSIVE AGENTS; CELL SURVIVAL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; RETINAL GANGLION CELLS;

EID: 84860427250     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.11.003     Document Type: Article

References (40)

1. H.A. Quigley, A.T. Broman The number of people with glaucoma worldwide in 2010 and 2020 Br J Ophthalmol 90 2006 262 267 (Pubitemid 43325451)
2. J.L. Goldberg The optic nerve L.A. Levin, S.F. Nilsson, J. Ver Hoeve, Adler's Physiology of the Eye 11th ed. 2011 Saunders/Elsevier New York
3. R.R. Allingham, Y. Liu, D.J. Rhee The genetics of primary open-angle glaucoma: a review Exp Eye Res 88 2009 837 844
4. Y. Liu, S. Schmidt, X. Qin No association between OPA1 polymorphisms and primary open-angle glaucoma in three different populations Mol Vis [serial online] 13 2007 2137 2141 http://www.molvis.org/molvis/v13/a242/ Accessed November 2, 2011 (Pubitemid 350200389)
5. M. Fitzgerald, S.C. Payne, C.A. Bartlett Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine Invest Ophthalmol Vis Sci 50 2009 5456 5462
6. V.P. Costa, E.S. Arcieri, A. Harris Blood pressure and glaucoma Br J Ophthalmol 93 2009 1276 1282
7. E.M. Ullian, W.B. Barkis, S. Chen Invulnerability of retinal ganglion cells to NMDA excitotoxicity Mol Cell Neurosci 26 2004 544 557 (Pubitemid 38969951)
8. A.H. Neufeld Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma Brain Res Bull 62 2004 455 459 (Pubitemid 38253028)
9. I.H. Pang, E.C. Johnson, L. Jia Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage Invest Ophthalmol Vis Sci 46 2005 1313 1321 (Pubitemid 41685871)
10. R.G. Corredor, J.L. Goldberg Electrical activity enhances neuronal survival and regeneration J Neural Eng 6 2009 055001
11. N. Gupta, J. Fong, L.C. Ang, Y.H. Yucel Retinal tau pathology in human glaucomas Can J Ophthalmol 43 2008 53 60 (Pubitemid 351269569)
12. M. Shimazawa, Y. Inokuchi, Y. Ito Involvement of ER stress in retinal cell death Mol Vis [serial online] 13 2007 578 587 http://www.molvis.org/molvis/ v13/a62/ Accessed November 2, 2011 (Pubitemid 46561917)
13. J.L. Goldberg, R.G. Corredor Retinal ganglion cell life and death: mechanisms and implications for ophthalmology Eur Ophthalmic Rev 3 2009 109 112
14. W. Hare, E. WoldeMussie, R. Lai Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey Surv Ophthalmol 45 Suppl 2001 S284 S289 discussion S295-6
15. C. Maier, G.K. Steinberg, G.H. Sun Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia Anesthesiology 79 1993 306 312 (Pubitemid 23224843)
16. T. Matsuo, M.S. Cynader Localization of alpha-2 adrenergic receptors in the human eye Ophthalmic Res 24 1992 213 219
17. E. WoldeMussie, G. Ruiz, M. Wijono, L.A. Wheeler Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension Invest Ophthalmol Vis Sci 42 2001 2849 2855 (Pubitemid 33035282)
18. T. Krupin, J.M. Liebmann, D.S. Greenfield Low-Pressure Glaucoma Study Group A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-pressure Glaucoma Treatment Study Am J Ophthalmol 151 2011 671 681
19. W.A. Lagreze, A. Pielen, R. Steingart The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro Invest Ophthalmol Vis Sci 46 2005 933 938 (Pubitemid 41321030)
20. D.L. Moore, M.G. Blackmore, Y. Hu KLF family members regulate intrinsic axon regeneration ability Science 326 2009 298 301
21. K.K. Park, K. Liu, Y. Hu Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway Science 322 2008 963 966
22. P.D. Smith, F. Sun, K.K. Park SOCS3 deletion promotes optic nerve regeneration in vivo Neuron 64 2009 617 623
23. D.L. Moore, J.L. Goldberg Four steps to optic nerve regeneration J Neuroophthalmol 30 2010 347 360
24. J.L. Goldberg, B.A. Barres The relationship between neuronal survival and regeneration Annu Rev Neurosci 23 2000 579 612 (Pubitemid 30350055)
25. K. Zhang, J.J. Hopkins, J.S. Heier Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration Proc Natl Acad Sci U S A 108 2011 6241 6245
26. A. Lambiase, L. Aloe, M. Centofanti Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma Proc Natl Acad Sci U S A 106 2009 13469 13474
27. Z. Shi, E. Birman, H.U. Saragovi Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo Dev Neurobiol 67 2007 884 894 (Pubitemid 47066919)
28. D. Fischer, M. Pavlidis, S. Thanos Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture Invest Ophthalmol Vis Sci 41 2000 3943 3954
29. T.V. Johnson, N.D. Bull, D.P. Hunt Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma Invest Ophthalmol Vis Sci 51 2010 2051 2059
30. M.J. Fredette, D.R. Anderson, V. Porciatti, W. Feuer Reproducibility of pattern electroretinogram in glaucoma patients with a range of severity of disease with the new glaucoma paradigm Ophthalmology 115 2008 957 963 (Pubitemid 351756511)
31. M. Sehi, M. Pinzon-Plazas, W.J. Feuer, D.S. Greenfield Relationship between pattern electroretinogram, standard automated perimetry, and optic nerve structural assessments J Glaucoma 18 2009 608 617
32. L.M. Ventura, V. Porciatti Pattern electroretinogram in glaucoma Curr Opin Ophthalmol 17 2006 196 202 (Pubitemid 43790817)
33. L.M. Ventura, V. Porciatti Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study Ophthalmology 112 2005 20 27 (Pubitemid 40075313)
34. M. Sehi, D.S. Grewal, M.L. Goodkin, D.S. Greenfield Reversal of retinal ganglion cell dysfunction after surgical reduction of intraocular pressure Ophthalmology 117 2010 2329 2336
35. T.S. Prata, M.V. Piassi, L.A. Melo Jr Changes in visual function after intraocular pressure reduction using antiglaucoma medications Eye (Lond) 23 2009 1081 1085
36. V. Parisi, G. Manni, G. Colacino, M.G. Bucci Cytidine-5′- diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma Ophthalmology 106 1999 1126 1134 (Pubitemid 30191515)
37. R. Rejdak, J. Toczolowski, J. Kurkowski Oral citicoline treatment improves visual pathway function in glaucoma Med Sci Monit 9 2003 PI24 PI28
38. C. Gall, A.B. Fedorov, L. Ernst Repetitive transorbital alternating current stimulation in optic neuropathy NeuroRehabilitation 27 2010 335 341
39. R.N. Weinreb, P.L. Kaufman The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium Invest Ophthalmol Vis Sci 50 2009 1497 1505
40. R.T. Chang, D.L. Budenz Diagnosing glaucoma progression Int Ophthalmol Clin 48 2008 13 28